TriMas Corporation
$36.77-$0.95 (-2.5%)
Last close · Data as of Nov 20, 2026
- Market cap
- $1.4B
- P/E
- 11.8x
- EV / EBITDA
- 19.0x
- Revenue
- $645.7M
- Net margin
- 18.6%
- ROCE
- 0.7%
Price chart
Technical chartScreen technicals →+15.7% over the last year
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 20 Nov 2026 close.
- 1M
- -7.4%
- 3M
- -4.7%
- 6M
- -6.2%
- 1Y
- +15.7%
- 5Y
- +3.3%
52-week range
Day change -$0.95 (-2.5%) from $38 to $37 · Last close Nov 20, 2026
Best weekday to invest, historically
The same weekly amount in TRS, bought on each weekday since 2021.
News & filings
What TriMas filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockStrengthNet margin of 18.6% against a peer median of 2.6%.
Concerns (1)
- Operating margin fell for three years, from 7.8% to 1.4%.
Prices to the 20 Nov 2026 close · Financial year: fiscal 2025
Rule-based from financial data. Not advice.
About the company
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace and defense, and industrial markets worldwide. The company operates through Packaging and Specialty Products segments.
Read moreShow less
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace and defense, and industrial markets worldwide. The company operates through Packaging and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Aarts Packaging, Intertech, Omega Plastics, and Rapak brands. The Specialty Products segment designs, manufactures, and distributes steel cylinders for use in transportation, storage, and dispensing of packaged and compressed gases under the Norris Cylinder brand. It sells its products through a direct sales force, third-party agents, and distributors. The company was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.
- Sector
- Consumer Cyclical
- Shares outstanding
- 40.5M
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- $1.4B
- P/E
- 11.8x
- P/B
- 2.0x
- EV / EBITDA
- 19.0x
- EV / Sales
- 2.9x
- P/S
- 2.2x
- 52-week high
- $45.03
- 52-week low
- $31.77
Profitability
- Operating margin
- 1.4%
- Net margin
- 18.6%
- EBITDA margin
- 15.4%
- ROE
- 17.0%
- ROCE
- 0.7%
- ROIC
- 3.6%
- ROA
- 8.1%
- Asset turnover
- 0.43
Growth
- RevenueFY2025, the latest fiscal year in the company's growth history.
- $645.7M
- Revenue growth, 1YFY2025, the latest fiscal year in the company's growth history.
- 2.4%
- Revenue CAGR, 3YFY2025, the latest fiscal year in the company's growth history.
- -9.9%
- Net profit growth, 1YFY2025, the latest fiscal year in the company's growth history.
- 395.4%
- Free cash flowFY2025, the latest fiscal year in the company's growth history.
- $69.1M
Solvency
- Current ratio
- 2.52
- Debt / Equity
- 0.72
- Debt / Assets
- 0.34
- CFO / Net profit
- 0.98
- Cash / Market cap
- 2.1%
Where the revenue went
Of every $100 of FY2025 revenue, $19 was left as net income.
| From | To | Amount |
|---|---|---|
| Revenue | Cost of revenue | $507.6M |
| Revenue | Gross profit | $138.2M |
| Gross profit | Selling, general and administrative | $129.3M |
| Gross profit | Other operating expenses | $0.00 |
| Gross profit | Operating income | $8.8M |
| Operating income | Pretax income | $8.8M |
| Interest and other income | Pretax income | $15.4M |
| Pretax income | Net income | $24.3M |
| Tax benefit and other | Net income | $95.9M |
Revenue and net profit
Revenue grew 2.4% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2022 | $883.8M | $66.2M |
| FY2023 | $652.1M | $40.4M |
| FY2024 | $630.8M | $24.3M |
| FY2025 | $645.7M | $120.1M |
Cash flows
FY2025: $117.5M from operations, $69.1M free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2022 | $72.6M | $26.6M |
| FY2023 | $88.2M | $34.0M |
| FY2024 | $63.8M | $12.8M |
| FY2025 | $117.5M | $69.1M |
Growth
Latest fiscal year 2025: each figure with its change over the year before.
- Revenue
- $645.7M+2.4%1Y
- EBITDA
- $99.3M+23.7%1Y
- Net profit
- $120.1M+395.4%1Y
- Cash from operations
- $117.5M+84.1%1Y
- Free cash flow
- $69.1M+439.0%1Y
- Revenue CAGR, 3Y
- -9.9%
- Net profit CAGR, 3Y
- 22.0%
| Year | Revenue | EBITDA | Net profit | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|
| FY2025 | $645.7M | $99.3M | $120.1M | $69.1M | 17.0% | +2.4% | +395.4% |
Monthly returns
Month-by-month returns of TRS across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Assets | $1.5B |
| Current assets | $462.7M |
| Non-current assets | $1.0B |
| Liabilities | $779.5M |
| Current liabilities | $183.7M |
| Non-current liabilities | $595.8M |
| Equity | $705.6M |
| Paid-in capital | $577.8M |
| Retained earnings | $127.4M |
Market cap against peers
8 peers: same sector, nearest by size.
Peers map
Consumer Cyclical companies placed by value, growth and quality; TRS highlighted.
P/E against peers
TRS trades at 11.8x earnings against a peer median of 18.9x (a 37% discount).
Not shown (no positive earnings and no EV / Sales): Lindblad Expeditions Holdings, Inc., Olaplex Holdings, Inc.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| TriMas CorporationTRSthis companyP/E ↓ discount | $1.4B | 11.8x | 2.0x | 17.0% | 19.0x |
| Lindblad Expeditions Holdings, Inc.LIND | $1.5B | -49.0x | -5.1x | 10.4% | 21.2x |
| Savers Value Village, Inc.SVV | $1.4B | 62.2x | 3.2x | 5.2% | 15.0x |
| Carter's, Inc.CRI | $1.4B | 15.3x | 1.5x | 9.9% | 10.5x |
| Leggett & Platt, IncorporatedLEG | $1.4B | 5.9x | 1.4x | 23.0% | 5.1x |
| Tripadvisor, Inc.TRIP | $1.4B | 34.8x | 2.2x | 6.2% | 8.0x |
| Revolve Group, Inc.RVLV | $1.4B | 22.4x | 2.7x | 12.0% | 13.9x |
| Olaplex Holdings, Inc.OLPX | $1.4B | -148.2x | 1.6x | -1.1% | 15.8x |
| Winmark CorporationWINA | $1.4B | 32.7x | — | -77.6% | 24.9x |
| Peer median | — | 18.9x | 1.6x | 8.1% | 14.5x |
Year-to-date ROI
TRS since 1 January, against earlier years.
Historical volatility
TRS's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
Consolidated figures in USD, fiscal years, newest first.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2022 | 8.7% |
| FY2023 | 7.8% |
| FY2024 | 3.2% |
| FY2025 | 1.4% |
| Line | FY2025 |
|---|---|
| RevenueTotal Revenue | $645.7M |
| Cost of revenueCost Of Revenue | $507.6M |
| Gross profitGross Profit | $138.2M |
| Operating expensesOperating Expense | $129.3M |
| Selling, general and administrativeSelling General And Administration | $129.3M |
| Total expensesTotal Expenses | $636.9M |
| Operating incomeOperating Income | $8.8M |
| Interest and other | |
| Pretax incomePretax Income | $24.3M |
| TaxTax Provision | -$48.0M |
| Net incomeNet Income | $120.1M |
| Per share | |
| Supplementary |
| Line | FY2025 |
|---|---|
| AssetsTotal Assets | $1.5B |
| Current assetsCurrent Assets | $462.7M |
| Non-current assetsTotal Non Current Assets | $1.0B |
| LiabilitiesTotal Liabilities Net Minority Interest | $779.5M |
| Current liabilitiesCurrent Liabilities | $183.7M |
| Non-current liabilitiesTotal Non Current Liabilities Net Minority Interest | $595.8M |
| EquityTotal Equity Gross Minority Interest | $705.6M |
| Supplementary |
| Line | FY2025 |
|---|---|
| Operating cash flowOperating Cash Flow | $117.5M |
| Cash from continuing operationsCash Flow From Continuing Operating Activities | $117.5M |
| Net income, continuing operationsNet Income From Continuing Operations | $120.1M |
| Depreciation and amortisationDepreciation And Amortization | $57.0M |
| Depreciation, amortisation and depletionDepreciation Amortization Depletion | $57.0M |
| Depreciation | $39.7M |
| Amortization cash flowAmortization Cash Flow | $17.3M |
| Amortization of intangiblesAmortization Of Intangibles | $17.3M |
| Stock-based compensationStock Based Compensation | $11.5M |
| Deferred taxDeferred Tax | -$37.4M |
| Deferred income taxDeferred Income Tax | -$37.4M |
| Operating gains and lossesOperating Gains Losses | -$4.5M |
| Asset impairmentAsset Impairment Charge | $0.00 |
| Provision and write off of assetsProvisionand Write Offof Assets | -$1.3M |
| Change in working capitalChange In Working Capital | $5.7M |
| Other non-cash itemsOther Non Cash Items | -$33.8M |
| Cash from discontinued operating activitiesCash From Discontinued Operating Activities | — |
| Investing cash flowInvesting Cash Flow | -$64.0M |
| Cash from continuing investingCash Flow From Continuing Investing Activities | -$64.0M |
| Capital expenditureCapital Expenditure | -$48.4M |
| Capital expenditure (reported)Capital Expenditure Reported | -$48.4M |
| Sale of PP&ESale Of PPE | $22.0M |
| Net PP&E purchases and salesNet PPE Purchase And Sale | $22.0M |
| AcquisitionsPurchase Of Business | -$37.7M |
| DisposalsSale Of Business | — |
| Net acquisitions and disposalsNet Business Purchase And Sale | -$37.7M |
| Purchase of investmentsPurchase Of Investment | $0.00 |
| Sale of investmentsSale Of Investment | $0.00 |
| Net investment purchases and salesNet Investment Purchase And Sale | $0.00 |
| Cash from discontinued investing activitiesCash From Discontinued Investing Activities | — |
| Financing cash flowFinancing Cash Flow | -$46.5M |
| Cash from continuing financingCash Flow From Continuing Financing Activities | -$46.5M |
| Debt issuedIssuance Of Debt | $356.3M |
| Debt repaidRepayment Of Debt | -$289.9M |
| Net debt issuedNet Issuance Payments Of Debt | $66.5M |
| Short-term debt issuedShort Term Debt Issuance | — |
| Short-term debt repaidShort Term Debt Payments | — |
| Net short-term debt issuedNet Short Term Debt Issuance | — |
| Long-term debt issuedLong Term Debt Issuance | $356.3M |
| Long-term debt repaidLong Term Debt Payments | -$289.9M |
| Net long-term debt issuedNet Long Term Debt Issuance | $66.5M |
| Net common stock issuedNet Common Stock Issuance | -$103.3M |
| Common stock repurchasedCommon Stock Payments | -$103.3M |
| Share buybacksRepurchase Of Capital Stock | -$103.3M |
| Stock options exercisedProceeds From Stock Option Exercised | -$2.0M |
| Dividends paidCash Dividends Paid | -$6.6M |
| Common dividends paidCommon Stock Dividend Paid | -$6.6M |
| Other financing chargesNet Other Financing Charges | -$970.0k |
| Cash from discontinued financing activitiesCash From Discontinued Financing Activities | — |
| Change in cashChanges In Cash | $7.0M |
| Cash at the start of the yearBeginning Cash Position | $23.1M |
| Cash at the end of the yearEnd Cash Position | $30.0M |
| Free cash flowFree Cash Flow | $69.1M |
| Supplemental |
Learn while you research
Academy chapters picked for TriMas Corporation and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Value InvestingA P/E of 11.8 could be a value opportunity, or a value trap. Know the difference.7 min read
- 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 04 Cyclical vs Defensive StocksConsumer staples behave defensively across the business cycle.6 min read
- 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read